Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Teva Pharmaceutical Industries Ltd. AGM Information 2007

Jun 6, 2007

7082_rns_2007-06-06_3f566a3e-f3b5-4817-af38-7b7164b8cd80.htm

AGM Information

Open in viewer

Opens in your device viewer

_________

C007��� ������ ��������� ��"�2PublicTEVA- PHARMACEUTICAL INDUSTRIES LTD.2530Corporation no: 520013954Stock Exchange/Market: ���310428P.O.B 3190 , Petach Tikva 49131 , ,Tel: 03-9267297 , 03-9267281 Fax: 03-9267429E.mail address: [email protected] of transmission: 06/06/2007              Time of broadcast: 09:07 08:37:42

Reference: 2007-02-418238

Israel Securities Authority Tel Aviv Stock Exchange
www.isa.gov.il www.tase.co.il

Annual General Meeting / Special MeetingRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000Only for corporation incorporated in Israel

On 17/07/2007 at 17:00 the corporation will hold it's annual general meetingat Teva's executive offices at 5 Basel Street, Petach Tikva, Israel.

According to section 182 B of the Companies law, 5759-1999, only shareholders of record at the close of business 11/06/2007 will be entitled to notice of, and to vote at, the Meeting.

Attached hereto is the report ����������060607_isa.pdf

Attached hereto is the proxy statement ����������060607_isa.pdf

The voting card will be filed next week, as a complementary report, on the date the proxy statement is filed with the US authorities.
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
Date of revision of form structure: 28/02/2007
- - -
Name of the Signatory: : Karniel Uzi , , Position of Signatory in the reporting corporation: General Counsel & Company Secretary
Basel Telephone: 03-9267297 , Facsimile: 03-9267429 , E-mail: [email protected]